| Misha D Miller, MD | |
|
777 Bannock St, Denver, CO 80204-4507 | |
| (303) 436-6000 | |
| Not Available |
| Full Name | Misha D Miller |
|---|---|
| Gender | Female |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 24 Years |
| Location | 777 Bannock St, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194802371 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
| Advanced Dermatology Skin Cancer And Laser Surgery Center P.c. | 6709775133 | 14 |
News Archive
An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.
In a recent study of patients with overactive bladder (OAB), a 30 mg extended release formulation of propiverine hydrochloride was at least as effective and safe as a 4 mg extended release formulation of tolterodine tartrate.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Sai Manoj Pudukotai Dinakarrao, Assistant Professor, Electrical and Computer Engineering, is developing a scalable and connectivity-aware solution that he hopes will help confine the COVID-19 pandemic and future epidemics.
› Verified 7 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.
In a recent study of patients with overactive bladder (OAB), a 30 mg extended release formulation of propiverine hydrochloride was at least as effective and safe as a 4 mg extended release formulation of tolterodine tartrate.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Sai Manoj Pudukotai Dinakarrao, Assistant Professor, Electrical and Computer Engineering, is developing a scalable and connectivity-aware solution that he hopes will help confine the COVID-19 pandemic and future epidemics.
› Verified 7 days ago
| Entity Name | Advanced Dermatology Skin Cancer & Laser Surgery Center P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134170012 PECOS PAC ID: 6709775133 Enrollment ID: O20040313000244 |
News Archive
An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.
In a recent study of patients with overactive bladder (OAB), a 30 mg extended release formulation of propiverine hydrochloride was at least as effective and safe as a 4 mg extended release formulation of tolterodine tartrate.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Sai Manoj Pudukotai Dinakarrao, Assistant Professor, Electrical and Computer Engineering, is developing a scalable and connectivity-aware solution that he hopes will help confine the COVID-19 pandemic and future epidemics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Misha D Miller, MD 777 Bannock St, Denver, CO 80204-4507 Ph: (303) 436-6000 | Misha D Miller, MD 777 Bannock St, Denver, CO 80204-4507 Ph: (303) 436-6000 |
News Archive
An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.
In a recent study of patients with overactive bladder (OAB), a 30 mg extended release formulation of propiverine hydrochloride was at least as effective and safe as a 4 mg extended release formulation of tolterodine tartrate.
In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.
As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.
Sai Manoj Pudukotai Dinakarrao, Assistant Professor, Electrical and Computer Engineering, is developing a scalable and connectivity-aware solution that he hopes will help confine the COVID-19 pandemic and future epidemics.
› Verified 7 days ago
Drew Michael Taylor, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3773 E Cherry Creek North Dr Ste 970, Denver, CO 80209 Phone: 303-388-5629 | |
Dr. William J Bowman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3464 S Willow St, Suite 194, Denver, CO 80231 Phone: 303-755-2900 Fax: 303-745-7997 | |
Samantha J Lewis, CRNP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-602-6196 | |
Dr. Patricia A Sinoway, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-4545 | |
Dr. Elisa Suzanne Kapler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Brian Woodford Petersen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1375 E 20th Ave, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Neil J Silverman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-4545 |